DG
Daina Graybosch Leerink Partners Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
Summit Therapeutics
SMMT
$19.3B
| $25.98 | $12 |
54%
downside
| Underperform | 2 months ago |
|
2
Merck
MRK
$212B
| $84.71 | $119 |
40%
upside
| Outperform | 7 months ago |
|
3
Arcellx
ACLX
$4.03B
| $72.62 | $39 |
46%
downside
| Outperform | 2 years ago |
|
4
Nektar Therapeutics
NKTR
$764M
| $40.18 | $45 |
12%
upside
| Market Perform | 2 years ago |
|
|
5
Merck
MRK
$212B
| $84.71 | $122 |
44%
upside
| Outperform | 2 years ago |
|
6
Arcus Biosciences
RCUS
$1.3B
| $12.19 | $38 |
212%
upside
| Outperform | 2 years ago |
|
7
BioNTech
BNTX
$27B
| $112.46 | $224 |
99%
upside
| Outperform | 3 years ago |
|